StockData
Nasus Pharma Ltd logo

Nasus Pharma Ltd (NSRX) stock

NSRXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 25, 2026Score 6/30
$2.61−0.05 (-1.88%)

Close on Nov 17, 2026Market cap $23.53MP/E –Yield –

Nasus Pharma operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -$4.92M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$4.92M–
FY2024Dec 31, 2024-$665.00K–
FY2023Dec 31, 2023-$1.03M–

More Nasus Pharma figures

See a number that looks wrong?